Jonathan Lieber

Jon Lieber

Jon has more than 25 years of experience in financial and executive management for emerging and growth-stage life science companies. He most recently served as CFO of Histogenics Corporation, a publicly-held cell therapy company developing products for the orthopedics market. Prior to Histogenics he served as the CFO for companies including  Metamark Genetics, Inc., Repligen Corporation, Xcellerex (acquired by GE Healthcare) and Altus Pharmaceuticals, Inc. Jon was previously an investment banker for 10 years, during which time he originated and executed on numerous corporate financings and merger and acquisition transactions at SG Cowen and Salomon Brothers. He currently serves on the board of Salarius Pharmaceuticals (NASDAQ: SLRX).

Jon holds a BS in Business Administration and Finance from Boston University and an MBA in Finance from New York University Stern School of Business.

Select Achievements

  • Raised more than $400 million in equity and debt in public and private securities offerings
  • Led $110 million IPO as CFO of Altus Pharmaceuticals
  • Led strategic transactions including the successful sale of Xcellerex to GE Healthcare

Specialties

Strategic planning
Capital raising
IPO preparation
Budgeting and financial reporting
Mergers and acquisitions
Investor relations